Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

June 2026; Volume 46,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abe, RYUDAI

    1. You have access
      Pretreatment Tumor Growth Rate and Clinical Outcomes in Advanced Non–small Cell Lung Cancer
      YUTAKA TAKAHARA, RYUDAI ABE, SUMITO NAGAE, TAKUYA TANAKA, YOKO ISHIGE, IKUYO SHIONOYA, KOUICHI YAMAMURA, MASAFUMI NOJIRI and MASAHARU IGUCHI
      Anticancer Research June 2026, 46 (6) 3407-3415; DOI: https://doi.org/10.21873/anticanres.18208
  2. Abe, SHINJI

    1. You have access
      Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer
      KAZUKI MAEDA, SOTA KOYAMA, KEI KAWADA, TOSHINOBU HAYASHI, TOSHIHIKO YOSHIOKA, TOMOAKI ISHIDA, HITOSHI FUKUDA, IO HORIKAWA, FUKA AIZAWA, TAKAHIRO NIIMURA, KENTA YAGI, MITSUHIRO GODA, YUKI IZAWA-ISHIZAWA, SHINJI ABE and KEISUKE ISHIZAWA
      Anticancer Research June 2026, 46 (6) 3191-3203; DOI: https://doi.org/10.21873/anticanres.18190
  3. Abe, YUKO

    1. Open Access
      Low-dose Andrographolide Synergizes With Cytarabine or Vincristine in Plasma Cell Neoplasm Cell Lines
      HIROKI DOI, HIDEHIKO AKIYAMA, TAEI MATSUI, YUKO ABE, SUMIE FUJII, HIDEAKI MATSUURA and YASUO MIURA
      Anticancer Research June 2026, 46 (6) 3067-3077; DOI: https://doi.org/10.21873/anticanres.18181
  4. Aburatani, HIROYUKI

    1. You have access
      Genomic Profiling of Cancerous Areas, Dysplasia, and Background Mucosa in Ulcerative Colitis-associated Colorectal Cancer
      KAORUKO FUNAKOSHI, KAZUHITO SASAKI, KEISUKE HATA, HIROAKI NOZAWA, KOJI MURONO, SHIGENOBU EMOTO, YUICHIRO YOKOYAMA, TAKAHIDE SHINAGAWA, SHINJI KOHSAKA, AYA SHINOZAKI-USHIKU, TETSUO USHIKU, KATSUTOSHI ODA, KENJI TATSUNO, KIYOSHI MIYAGAWA, HIROYUKI ABURATANI, HIROYUKI MANO and SOICHIRO ISHIHARA
      Anticancer Research June 2026, 46 (6) 3281-3291; DOI: https://doi.org/10.21873/anticanres.18197
  5. Aizawa, FUKA

    1. You have access
      Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer
      KAZUKI MAEDA, SOTA KOYAMA, KEI KAWADA, TOSHINOBU HAYASHI, TOSHIHIKO YOSHIOKA, TOMOAKI ISHIDA, HITOSHI FUKUDA, IO HORIKAWA, FUKA AIZAWA, TAKAHIRO NIIMURA, KENTA YAGI, MITSUHIRO GODA, YUKI IZAWA-ISHIZAWA, SHINJI ABE and KEISUKE ISHIZAWA
      Anticancer Research June 2026, 46 (6) 3191-3203; DOI: https://doi.org/10.21873/anticanres.18190
  6. Akiyama, HIDEHIKO

    1. Open Access
      Low-dose Andrographolide Synergizes With Cytarabine or Vincristine in Plasma Cell Neoplasm Cell Lines
      HIROKI DOI, HIDEHIKO AKIYAMA, TAEI MATSUI, YUKO ABE, SUMIE FUJII, HIDEAKI MATSUURA and YASUO MIURA
      Anticancer Research June 2026, 46 (6) 3067-3077; DOI: https://doi.org/10.21873/anticanres.18181
  7. Ando, KEISUKE

    1. You have access
      Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate Cancer
      YASUTAKA YAMADA, MARIKA MATSUMOTO, MAI IKEHARA, TAKUYA TSUJINO, KODAI SATO, SHINPEI SAITO, YUKI YOSHIKAWA, RYOICHI MAENOSONO, SATOSHI YAMAMOTO, TAKAYUKI ARAI, HIROAKI SATO, KOSUKE HIGUCHI, AKINORI TAKEI, MANATO KANESAKA, KEISUKE ANDO, SANGJON PAE, SANJI KANAOKA, NOBUSHIGE TAKESHITA, KEI YONEDA, DAICHI HINO, TAKAAKI TAMURA, TOMOKAZU SAZUKA, YUSUKE IMAMURA, KAZUO MIKAMI, KAZUYOSHI NAKAMURA, SATOSHI FUKASAWA, AKIRA KUROZUMI, YUKIO NAYA, MAKI NAGATA, ATSUSHI KOMARU, TOYOFUSA TOBE, NORIYUKI SUZUKI, HARUHITO AZUMA and SHINICHI SAKAMOTO
      Anticancer Research June 2026, 46 (6) 3461-3472; DOI: https://doi.org/10.21873/anticanres.18214
  8. Ando, YUJI

    1. You have access
      Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer
      YUTA MURAI, KIICHI SUGIMOTO, TAKAHIRO IRIE, TAKASHI FUJISAKI, ATSUHIKO HAMADA, YUJI ANDO, SAKI KOCHI, MIYUKI TOAKE, YUKI NAKAGAWA, HIROMITSU TAKAHASHI, HIROTAKA MOMOSE, YUKI TSUCHIYA, RYOICHI TSUKAMOTO, HISASHI RO, KUMPEI HONJO, MAKOTO TAKAHASHI and ROBERT M. HOFFMAN
      Anticancer Research June 2026, 46 (6) 3267-3280; DOI: https://doi.org/10.21873/anticanres.18196
  9. Annazone, MELISSA

    1. Open Access
      Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort
      NICOLAS HULSCHER, KELLY VICTORY, JAMES A. THORP, DREW PINSKY, ALEJANDRO DIAZ-VILLALOBOS, PETER GILLOOLY, FOSTER COULSON, MELISSA ANNAZONE, CHLOE RADESI, JESSICA BROOKS, PETER A. McCULLOUGH and HARVEY RISCH
      Anticancer Research June 2026, 46 (6) 3243-3255; DOI: https://doi.org/10.21873/anticanres.18194
  10. Aoki, TAKESHI

    1. You have access
      Dual Biological Aggressiveness in Gastric MiNEN With Squamous Differentiation: A Case of Rapid Postoperative Peritoneal Dissemination
      SADAHITO ISEKI, TAKESHI AOKI, KIMIYASU YAMAZAKI, MAYUMI HOMMA, HIROMI DATE, KIYOTAKA MOCHIZUKI, KEN NAITO, KEISUKE OURA, TAKAO YOSHIDA and TOSHIKO YAMOCHI
      Anticancer Research June 2026, 46 (6) 3533-3540; DOI: https://doi.org/10.21873/anticanres.18221
« Previous (Pages : 1 2 3 4 5 6 ... 45) Next »
Back to top
Previous

In this issue

Anticancer Research: 46 (6)
Anticancer Research
Vol. 46, Issue 6
June 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)

Issue highlights

  • A Landscape of Immunogenomics Assessments for Endemic Burkitt Lymphoma: Relevance to Outcomes
  • Beneficial Effects of Combining an Immune Checkpoint Inhibitor With Proton Radiation, OXi4503, or Hyperthermia in a Murine Solid Tumor Model
  • A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice
  • Targeting Arginine Metabolism to Reverse Immune Paralysis in Cancer
  • Prior Chlamydia trachomatis Infection and the Risk of Epithelial Ovarian Cancer and Borderline Ovarian Tumors
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire